These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
783 related articles for article (PubMed ID: 27627196)
21. The novel YAP target gene, SGK1, upregulates TAZ activity by blocking GSK3β-mediated TAZ destabilization. Yoo G; Kim T; Chung C; Hwang DS; Lim DS Biochem Biophys Res Commun; 2017 Aug; 490(3):650-656. PubMed ID: 28634071 [TBL] [Abstract][Full Text] [Related]
22. OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ. Zhang Z; Du J; Wang S; Shao L; Jin K; Li F; Wei B; Ding W; Fu P; van Dam H; Wang A; Jin J; Ding C; Yang B; Zheng M; Feng XH; Guan KL; Zhang L Mol Cell; 2019 Jan; 73(1):7-21.e7. PubMed ID: 30472188 [TBL] [Abstract][Full Text] [Related]
23. YAP/TAZ enhances P-body formation to promote tumorigenesis. Shen X; Peng X; Guo Y; Dai Z; Cui L; Yu W; Liu Y; Liu CY Elife; 2024 Jul; 12():. PubMed ID: 39046443 [TBL] [Abstract][Full Text] [Related]
24. The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications. Maugeri-Saccà M; Barba M; Pizzuti L; Vici P; Di Lauro L; Dattilo R; Vitale I; Bartucci M; Mottolese M; De Maria R Expert Rev Mol Med; 2015 Jul; 17():e14. PubMed ID: 26136233 [TBL] [Abstract][Full Text] [Related]
25. YAP/TAZ at the Roots of Cancer. Zanconato F; Cordenonsi M; Piccolo S Cancer Cell; 2016 Jun; 29(6):783-803. PubMed ID: 27300434 [TBL] [Abstract][Full Text] [Related]
26. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review. Crawford JJ; Bronner SM; Zbieg JR Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112 [No Abstract] [Full Text] [Related]
27. TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells. Diamantopoulou Z; White G; Fadlullah MZH; Dreger M; Pickering K; Maltas J; Ashton G; MacLeod R; Baillie GS; Kouskoff V; Lacaud G; Murray GI; Sansom OJ; Hurlstone AFL; Malliri A Cancer Cell; 2017 May; 31(5):621-634.e6. PubMed ID: 28416184 [TBL] [Abstract][Full Text] [Related]
28. Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies. Ng J; Cai L; Girard L; Prall OWJ; Rajan N; Khoo C; Batrouney A; Byrne DJ; Boyd DK; Kersbergen AJ; Christie M; Minna JD; Burr ML; Sutherland KD Clin Cancer Res; 2024 May; 30(9):1846-1858. PubMed ID: 38180245 [TBL] [Abstract][Full Text] [Related]
29. YAP/TAZ for cancer therapy: opportunities and challenges (review). Guo L; Teng L Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178 [TBL] [Abstract][Full Text] [Related]
30. Hippo pathway-independent restriction of TAZ and YAP by angiomotin. Chan SW; Lim CJ; Chong YF; Pobbati AV; Huang C; Hong W J Biol Chem; 2011 Mar; 286(9):7018-26. PubMed ID: 21224387 [TBL] [Abstract][Full Text] [Related]
31. Hypoxic conditions differentially regulate TAZ and YAP in cancer cells. Yan L; Cai Q; Xu Y Arch Biochem Biophys; 2014 Nov; 562():31-6. PubMed ID: 25078107 [TBL] [Abstract][Full Text] [Related]
32. Knockdown of TAZ modifies triple-negative breast cancer cell sensitivity to EGFR inhibitors by regulating YAP expression. Guo L; Zheng J; Zhang J; Wang H; Shao G; Teng L Oncol Rep; 2016 Aug; 36(2):729-36. PubMed ID: 27373987 [TBL] [Abstract][Full Text] [Related]
33. Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ. Ji J; Xu R; Zhang X; Han M; Xu Y; Wei Y; Ding K; Wang S; Bin Huang ; Chen A; Di Zhang ; Jiang Z; Xu S; Zhang Q; Li W; Ni S; Wang J; Li X Cell Death Dis; 2018 May; 9(5):517. PubMed ID: 29725063 [TBL] [Abstract][Full Text] [Related]
34. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ. Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125 [TBL] [Abstract][Full Text] [Related]
35. Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation. Kim MH; Kim J; Hong H; Lee SH; Lee JK; Jung E; Kim J EMBO J; 2016 Mar; 35(5):462-78. PubMed ID: 26668268 [TBL] [Abstract][Full Text] [Related]
36. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis. Wang KC; Yeh YT; Nguyen P; Limqueco E; Lopez J; Thorossian S; Guan KL; Li YJ; Chien S Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11525-11530. PubMed ID: 27671657 [TBL] [Abstract][Full Text] [Related]
37. Substratum stiffness and latrunculin B modulate the gene expression of the mechanotransducers YAP and TAZ in human trabecular meshwork cells. Thomasy SM; Morgan JT; Wood JA; Murphy CJ; Russell P Exp Eye Res; 2013 Aug; 113():66-73. PubMed ID: 23727052 [TBL] [Abstract][Full Text] [Related]
38. The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells. Slaninová V; Heron-Milhavet L; Robin M; Jeanson L; Aissanou A; Kantar D; Tosi D; Bréhélin L; Gongora C; Djiane A BMC Cancer; 2024 May; 24(1):587. PubMed ID: 38741073 [TBL] [Abstract][Full Text] [Related]
39. Antitumor activity of curcumin is involved in down-regulation of YAP/TAZ expression in pancreatic cancer cells. Zhou X; Su J; Feng S; Wang L; Yin X; Yan J; Wang Z Oncotarget; 2016 Nov; 7(48):79076-79088. PubMed ID: 27738325 [TBL] [Abstract][Full Text] [Related]
40. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development. Rozengurt E; Eibl G World J Gastroenterol; 2019 Apr; 25(15):1797-1816. PubMed ID: 31057295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]